Autophagy inhibition synergistically enhances anticancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells, and tumor xenografts

Molecular Cancer Therapeutics

Volumn 11, Issue 4, 2012, Pages 898-908

  Godbole, Abhijit M ^a,d   Purushottamachar, Puranik ^a,d   Martin, Marlena S ^a,d   Daskalakis, Constantine ^c   Njar, Vincent C O ^a,b,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BECLIN 1; CHLOROQUINE; UNCLASSIFIED DRUG; VN 12 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENDOPLASMIC RETICULUM STRESS; G1 PHASE CELL CYCLE CHECKPOINT; GENOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SKBR 3 CELL; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DRUG SYNERGISM; FEMALE; HUMANS; IMIDAZOLES; MICE; MICE, SCID; TRETINOIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84862742598     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-11-0860     Document Type: Article

References (44)

1. Trump DL, Smith DC, Stiff D, Adedoyin A, Day R, Bahnson RR, et al. A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis. Cancer Chemother Pharmacol 1997;39:349-56. (Pubitemid 27047480)
2. Phipps SM, Love WK, White T, Andrews LG, Tollefsbol TO. Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells. Anticancer Res 2009;29:4959-64.
3. Lee KH, Chang MY, Ahn JI, Yu DH, Jung SS, Choi JH, et al. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. BiochemBiophys Res Commun 2002;296:1125-33.
4. Njar VC. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy. Mini Rev Med Chem 2002;2:261-9.
5. Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, et al. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem 2006;14:4323-40. (Pubitemid 43728662)
6. Patel JB, Huynh CK, Handratta VD, Gediya LK, Brodie AM, Goloubeva OG, et al. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice. J Med Chem 2004;47:6716-29. (Pubitemid 40053761)
7. Patel JB, Mehta J, Belosay A, Sabnis G, Khandelwal A, Brodie AM, et al. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer 2007;96:1204-15. (Pubitemid 46628615)
8. Fang Y, Zhou X, Lin M, Jing H, Zhong L, Ying M, et al. The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation. Cancer Biol Ther 2010;10:1157-67.
9. Liu JJ, Lin M, Yu JY, Liu B, Bao JK. Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 2011;300:105-14.
10. Tschan MP, Simon HU. The role of autophagy in anticancer therapy: promises and uncertainties. J Intern Med 2010;268:410-8.
11. Xi H, Kurtoglu M, Liu H, Wangpaichitr M, You M, Liu X, et al. 2-Deoxy-D: -glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol 2011;67:899-910.
12. Maycotte P, Thorburn A. Autophagy and cancer therapy. Cancer Biol Ther 2011;11:127-37.
13. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS One 2009;4:e6251.
14. Fan QW, Cheng C, Hackett C, Feldman M, Houseman BT, Nicolaides T, et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 2010;3:ra81.
15. Schleicher SM, Moretti L, Varki V, Lu B. Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches. Drug Resist Updat 2010;13:79-86.
16. Heath-Engel HM, Chang NC, Shore GC. The endoplasmic reticulum in apoptosis and autophagy:role of the BCL-2 protein family. Oncogene 2008;27:6419-33.
17. Schonthal AH. Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett 2009;275:163-9.
18. deFazio A, Chiew YE, Sini RL, Janes PW, Sutherland RL. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 2000;87:487-98. (Pubitemid 30639806)
19. Bossi G, Lapi E, Strano S, Rinaldo C, Blandino G, Sacchi A. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene 2006;25:304-9. (Pubitemid 43083692)
20. Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe ML, Morrison SL, Penichet ML, et al. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein. Mol Cancer Ther 2005;4:956-67. (Pubitemid 40909078)
21. Xu YM, Wang LF, Jia LT, Qiu XC, Zhao J, Yu CJ, et al. A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors. J Immunol 2004;173:61-7. (Pubitemid 38797326)
22. Turur VR SD, Chaudhari CJ, Joshi MA. A one pot process for the preparationof4-[ (1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile. In: World Intellectual Property Organization. Patent No: WO 2007/039912 A1; Published 12 April 2007.
23. Jones JW. RR potential purine antagonist. XXX. Purine betaines and related derivatives prepared by direct methylation of the simple purines. J Am Chem Society 1962;84:1914-9.
24. Bruno RD, Gover TD, Burger AM, Brodie AM, Njar VC. 17alpha-Hydroxylase/ 17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response. Mol Cancer Ther 2008;7:2828-36.
25. Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 2009;119:1109-23.
26. Lee SJ, Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, et al. Effects of all-trans retinoic acid on sodium/iodide symporter and CCAAT/enhancer-binding protein-homologous protein under condition of endoplasmic reticulum stress in FRTL5 thyroid cells. HormMetab Res 2011;43:331-6.
27. Ohashi E, Kogai T, Kagechika H, Brent GA. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Res 2009;69:3443-50.
28. Kogai T, Ohashi E, Jacobs MS, Sajid-Crockett S, Fisher ML, Kanamoto Y, et al. Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways. J Clin Endocrinol Metab 2008;93:1884-92. (Pubitemid 351656534)
29. Gregersen N, Bross P. Protein misfolding and cellular stress: an overview. Methods Mol Biol 2010;648:3-23.
30. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004;11:381-9. (Pubitemid 38489416)
31. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27-42.
32. Tasdemir E, Galluzzi L, Maiuri MC, Criollo A, Vitale I, Hangen E, et al. Methods for assessing autophagy and autophagic cell death. Methods Mol Biol 2008;445:29-76.
33. Pan Y, Gao Y, Chen L, Gao G, Dong H, Yang Y, et al. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clin Cancer Res 2011;17:3248-58.
34. Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond. Trends Cell Biol 2010;20:355-62.
35. Shinojima N, Yokoyama T, Kondo Y, Kondo S. Roles of the Akt/mTOR/ p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 2007;3:635-7. (Pubitemid 350060068)
36. Klionsky DJ, Meijer AJ, Codogno P. Autophagy and p70S6 kinase. Autophagy 2005;1:59-60; discussion 60-1.
37. Chang YY, Juhasz G, Goraksha-Hicks P, Arsham AM, Mallin DR, Muller LK, et al. Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans 2009; 37:232-6.
38. Xie BS, Zhao HC, Yao SK, Zhuo DX, Jin B, Lv DC, et al. Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med 2011;27:599-606.
39. Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010;70:440-6.
40. Chien DS, Sandri RB, Tang-Liu DS. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats. Drug Metab Dispos 1992;20:211-7.
41. Thacher SM, Nagpal S, Klein ES, Arefieg T, Krasinski G, DiSepio D, et al. Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes. Cell Growth Differ 1999;10:255-62. (Pubitemid 29196661)
42. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, et al. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol Cancer Ther 2008;7:2977-87.
43. Wu Z, Chang PC, Yang JC, Chu CY, Wang LY, Chen NT, et al. Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors. Genes Cancer 2010;1:40-9.
44. Chattopadhaya S, Abu Bakar FB, Yao SQ. Expanding the chemical biologist's tool kit: chemical labelling strategies and its applications. Curr Med Chem 2009;16:4527-43.